中国组织工程研究 ›› 2025, Vol. 29 ›› Issue (32): 6828-6835.doi: 10.12307/2025.970

• 骨组织构建 bone tissue construction • 上一篇    下一篇

健骨方对破骨细胞-成骨细胞的偶联效应及作用机制

卢秀丽1,许华珍1,陈玉兴2,3,姚  楠2,3,胡子旋2,3,黄丹娥2,3   

  1. 1广州中医药大学第五临床医学院,广东省广州市  510095;2广东省第二中医院(广东省中医药工程技术研究院),广东省广州市  510095;3广东省中医药研究开发重点实验室,广东省广州市  510095
  • 收稿日期:2024-06-17 接受日期:2024-08-28 出版日期:2025-11-18 发布日期:2025-04-25
  • 通讯作者: 黄丹娥,副主任药师,广东省第二中医院(广东省中医药工程技术研究院),广东省广州市 510095;广东省中医药研究开发重点实验室,广东省广州市 510095
  • 作者简介:卢秀丽,女,2000年生,广州中医药大学第五临床医学院在读硕士,主要从事中药药理学方面的研究。
  • 基金资助:
    国家自然科学基金面上项目(82104473),项目负责人:黄丹娥;国家自然科学基金青年科学基金项目(82474347),项目负责人:黄丹娥;广东省自然科学基金(2023A1515010752),项目负责人:黄丹娥;广东省第二中医院科研创新基金项目(SEZYY2023A02),项目负责人:姚楠

Mechanism of Jiangu Formula in treating osteoporosis based on osteoclast-osteoblast coupling

Lu Xiuli1, Xu Huazhen1, Chen Yuxing2, 3, Yao Nan2, 3, Hu Zixuan2, 3, Huang Dane2, 3   

  1. 1The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510095, Guangdong Province, China; 2Guangdong Provincial Second Hospital of Traditional Chinese Medicine (Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine), Guangzhou 510095, Guangdong Province, China; 3Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine, Guangzhou 510095, Guangdong Province, China
  • Received:2024-06-17 Accepted:2024-08-28 Online:2025-11-18 Published:2025-04-25
  • Contact: Huang Dane, Associate chief pharmacist, Guangdong Provincial Second Hospital of Traditional Chinese Medicine (Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine), Guangzhou 510095, Guangdong Province, China; 3Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine, Guangzhou 510095, Guangdong Province, China
  • About author:Lu Xiuli, Master candidate, The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510095, Guangdong Province, China
  • Supported by:
    National Natural Science Foundation of China (General Program), No. 82104473 (to HDE); National Natural Science Foundation of China (Youth Program), No. 82474347 (to HDE); Natural Science Foundation of Guangdong Province, No. 2023A1515010752 (to HDE); Guangdong Second Hospital of Traditional Chinese Medicine Scientific Research and Innovation Fund Project, No. SEZYY2023A02 (to YN)

摘要:


文题释义:
健骨方:参考广东省第二中医临床应用效果较佳的经验方,在中医基础理论的指导下,根据《太平圣惠方》治腰脚疼痛不止方和《医学启源》生脉散方加减化载而成。健骨方处方包含了骨碎补、牛膝、千年健、补骨脂、人参、麦冬、鸡血藤等7味中药。前期研究发现,健骨方可以通过抑制骨吸收促进骨形成起到双效抗骨质疏松治疗作用。
骨吸收-骨形成偶联:破骨细胞在分化、成熟过程中通过释放一些“偶联因子”如鞘氨醇-1-磷酸、Slit同源物3和补体C3a等,这些“偶联因子”的释放会诱导成骨细胞分化、沉积形成新骨,这个现象称为骨吸收-骨形成的“偶联”,是一种破骨细胞与成骨细胞之间的通讯方式。

背景:前期研究发现,健骨方可以通过抑制骨吸收促进骨形成起到双效抗骨质疏松的治疗作用,但其作用机制尚未阐明。
目的:考察健骨方对骨吸收-骨形成的偶联效应和作用机制。
方法:制备健骨方含药血清,通过MTT法测定健骨方含药血清对小鼠骨髓源巨噬细胞的毒性;应用CCK-8法测定健骨方含药血清对MC3T3-E1细胞增殖能力的影响;采用抗酒石酸酸性磷酸酶染色法测定健骨方含药血清对破骨细胞分化的抑制作用;制备健骨方条件培养基,通过碱性磷酸酶染色测定条件培养基偶联促进MC3T3-E1细胞成骨分化的作用;RT-qPCR法测定健骨方含药血清对破骨细胞偶联基因鞘氨醇激酶2、含胶原三螺旋重复蛋白1、Slit同源物3 mRNA水平以及条件培养基对骨形成相关基因分泌型磷酸蛋白1、碱性磷酸酶、SP7转录因子、酸性富含半胱氨酸分泌型蛋白 mRNA水平的影响。 
结果与结论:①MTT法和CCK-8法结果显示,健骨方含药血清在低于5%浓度下对细胞无显著毒性作用;②抗酒石酸酸性磷酸酶染色结果显示,健骨方含药血清在2.5%、1.25%和0.63%浓度时剂量依赖性抑制破骨细胞的分化;③碱性磷酸酶染色结果显示,健骨方破骨细胞条件培养基呈剂量依赖性地促进成骨细胞分化;④RT-qPCR检测结果显示,0.63%健骨方含药血清可以提高破骨细胞源性偶联因子Slit同源物3和鞘氨醇激酶2的mRNA水平,其条件培养基可以提高骨形成相关基因分泌型磷酸蛋白1、SP7转录因子和酸性富含半胱氨酸分泌型蛋白mRNA表达水平;⑤提示健骨方含药血清能够在抑制骨吸收的情况下促进骨形成,其机制可能与促进骨吸收-骨形成偶联因子Slit同源物3和鞘氨醇激酶2的mRNA表达有关。
https://orcid.org/0009-0002-1160-9834(卢秀丽)

中国组织工程研究杂志出版内容重点:组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松;组织工程

关键词: 健骨方, 骨吸收, 骨形成, 骨质疏松症, 偶联, 破骨细胞, 成骨细胞, 骨稳态, 工程化组织构建

Abstract: BACKGROUND: Previous studies have found that Jiangu Formula can play a dual role in anti-osteoporosis therapy by inhibiting bone resorption and promoting bone formation, but its mechanism of action has not been elucidated. 
OBJECTIVE: To investigate the effect of Jiangu Formula on the coupling mechanism between bone resorption and bone formation at the cellular and molecular levels. 
METHODS: Serum containing Jiangu Formula was prepared and its toxicity to bone marrow derived macrophages was determined using MTT assay. The cell proliferation ability of MC3T3-E1 cells that treated Jiangu Formula medicated serum was measured by using cell counting kit-8 method. Tartrate resistant acid phosphatase staining was used to determine the bone resorption inhibition effect of serum containing Jiangu Formula on osteoclast differentiation. The Jiangu Fang conditional culture medium was prepared and the promoting effect of the conditional culture medium on bone formation of MC3T3-E1 was determined through alkaline phosphatase staining. The effect of serum containing Jiangu Formula on the mRNA levels of osteoclast associated sphingosine kinase 2, collagen triple helix repeat containing 1, and slit homolog 3 coupled genes, as well as the effect of conditioned culture medium on the mRNA levels of bone formation related secreted phosphoprotein 1, alkaline phosphatase, Sp7 transcription factor, and secreted protein acidic and rich in cysteine genes, were determined by RT-qPCR method. 
RESULTS AND CONCLUSION: (1) The MTT and cell counting kit-8 methods showed that serum containing Jiangu Formula had no significant cytotoxic effects at a concentration of < 5%. (2) Tartrate resistant acid phosphatase staining results indicated that serum containing Jiangu Formula dose-dependently inhibited osteoclast differentiation at 2.5%, 1.25%, and 0.63% concentrations. (3) The alkaline phosphatase staining results showed that the osteoclast conditioned medium of Jiangu Formula promoted osteoblast differentiation in a dose-dependent manner. (4) In addition, RT-qPCR results showed that serum containing 0.63% Jiangu Formula could increase the mRNA levels of osteoclast derived slit homolog 3 and sphingosine kinase 2 coupling factors, and the conditional culture medium could increase the mRNA expression levels of bone formation related secreted phosphoprotein 1, Sp7 transcription factor, and secreted protein acidic and rich in cysteine. To conclude, the serum containing Jiangu Formula can promote bone formation while inhibiting bone resorption, and its mechanism may be related to the mRNA expression of the coupling factors osteoclast derived slit homolog 3 and sphingosine kinase 2 that promote bone resorption and bone formation.

Key words: Jiangu Formula, bone resorption, bone formation, osteoporosis, coupling, osteoclasts, osteoblasts, bone homeostasis, engineered tissue construction

中图分类号: